Design of Polymer-Drug Conjugates

Drug Delivery in Oncology: From Basic Research to Cancer Therapy

Volumn 2, Issue , 2011, Pages 483-512

  Kopeček, Jindřich ^a   Kopečková, Pavla ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Drug free macromolecular therapeutics; HPMA copolymer; Polymer drug carrier; Subcellular targeting; Targeting; Water soluble polymer

Indexed keywords

EID: 84887156796     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527634057.ch17     Document Type: Chapter

References (107)

1. Ehrlich, P. (1906) Studies in Immunity, Plenum Press, New York.
2. Jatzkewitz, H. (1955) Peptamin (glycyl-l-leucyl-mescaline) bound to blood plasma expander (polyvinylpyrrolidone) as a new depot form of a biologically active primary amine (mescaline). Z. Naturforsch., 10b, 27-31.
3. Givetal, N.I., Ushakov, S.N., Panarin, E.F., and Popova, G.O. (1965) [Experimental studies on penicillin polymer derivatives]. Antibiotiki, 10, 701-706.
4. Shumikina, K.I., Panarin, E.F., and Ushakov, S.N. (1966) [Experimental study of polymer salts of penicillins]. Antibiotiki, 11, 767-770.
5. Panarin, E.F. and Ushakov, S.N. (1968) [Synthesis of polymer salts and amidopenicillines]. Khim. Pharm. Zhur., 2, 28-31.
6. Mathé, G., Loc, T.B., and Bernard, J. (1958) Effect sur la leucémie L1210 de la Souris d'une combinaison par diazotation d'a méthoptérine et de γ-globulines de hamsters porteurs de cette leucémie par hétérogreffe. C.R. Acad. Sci., 3, 1626-1628.
7. De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., and van Hoof, F. (1974) Lysosomotropic agents. Biochem. Pharmacol., 23, 2495-2531.
8. Ringsdorf, H. (1975) Structure and properties of pharmacologically active polymers. J. Polym. Sci. Polym. Symp., 51, 135-153.
9. Kopeček, J. (1977) Soluble biomedical polymers. Polim. Med., 7, 191-221.
10. Putnam, D., and Kopeček, J. (1995) Polymers with anticancer activity. Adv. Polym. Sci., 122, 55-123.
11. Conner, S.D., and Schmid, S.L. (2003) Regulated portals of entry into the cell. Nature, 422, 37-44.
12. Liu, J., Bauer, H., Callahan, J., Kopečková, P., Pan, H., and Kopeček, J. (2010) Endocytic uptake of a large array of HPMA copolymers: elucidation into the dependence on the physicochemical characteristics. J. Control. Release, 143, 71-79.
13. Duncan, R. (2003) The dawning era of polymer therapeutics. Nat. Rev. Drug Discov., 2, 347-360.
14. Ulbrich, K., and Šubr, V. (2004) Polymeric anticancer drugs with pH-controlled activation. Adv. Drug Deliv. Rev., 56, 1023-1050.
15. Haag, R., and Kratz, F. (2006) Polymer therapeutics: concepts and applications. Angew. Chem. Int. Ed., 45, 1198-1215.
16. Khandare, J., and Minko, T. (2006) Polymer-drug conjugates: progress in polymer prodrugs. Prog. Polym. Sci., 31, 359-397.
17. Li, C., and Wallace, S. (2008) Polymer-drug conjugates: recent development in clinical oncology. Adv. Drug Deliv. Rev., 60, 886-898.
18. Pan, H., and Kopeček, J. (2008) Multifunctional water-soluble polymers for drug delivery in Multifunctional Pharmaceutical Nanocarriers, Fundamental Biomedical Technologies, vol. 4 (ed. V.P. Torchilin), Springer, New York, pp. 81-142.
19. Kopeček, J., and Kopečková, P. (2010) HPMA copolymers: origins, early developments, present, and future. Adv. Drug Deliv. Rev., 62, 122-149.
20. Krinick, N.L., and Kopeček, J. (1991) Soluble polymers as targetable drug carriers in Targeted Drug Delivery, Handbook of Experimental Pharmacology, vol. 100 (ed. R.L. Juliano), Springer, Berlin, pp. 105-179.
21. Chiu, H.-C., Kopečková, P., Deshmane, S.S., and Kopeček, J. (1997) Lysosomal degradation of poly(a-amino acids). J. Biomed. Mater. Res., 34, 381-392.
22. Chiu, H.-C., Koňák, Č., Kopečková, P., and Kopeček, J. (1994) Enzymatic degradation of poly(ethylene glycol) modified dextrans. J. Bioact. Comp. Polym., 9, 388-410.
23. Lloyd, J.B. (2000) Lysosomal membrane permeability: implications for drug delivery. Adv. Drug Deliv. Rev., 41, 189-200.
24. Šprincl, L., Exner, J., Štěrba, O., and Kopeček, J. (1976) New types of synthetic infusion solutions. III Elimination and retention of poly[N-(2-hydroxypropyl)methacrylamide] in a test organism. J. Biomed. Mater. Res., 10, 953-963.
25. Seymour, L.W., Duncan, R., Strohalm, J., and Kopeček, J. (1987) Effect of molecular weight of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal and intravenous administration to rats. J. Biomed. Mater. Res., 21, 1341-1358.
26. Hespe, W., Meier, A.M., and Blankwater, Y.J. (1977) Excretion and distribution studies in rats with two forms of 14 carbon-labeled polyvinylpyrrolidone with a relatively low mean molecular weight after intravenous administration. Drug Res., 27, 1158-1162.
27. Yamaoka, T., Tabata, Y., and Ikada, Y. (1993) Body distribution profile of polysaccharides after intravenous administration. Drug Deliv., 1, 75-82.
28. Kopeček, J. (1981) Soluble polymers in medicine, in Systemic Aspects of Biocompatibility, vol. II (ed. D.F. Williams), CRC Press, Boca Raton, FL, pp. 159-180.
29. Yamaoka, T., Tabata, Y., and Ikada, Y. (1995) Fate of water-soluble polymers administered via different routes. J. Pharm. Sci., 84, 349-354.
30. Lammers, T., Kühnlein, R., Kissel, M., Šubr, V., Etrych, T., Pola, R., Pechar, M., Ulbrich, K., Storm, G., Huber, P., and Peschke, P. (2005) Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. J. Control. Release, 110, 103-118.
31. Dvořák, M., Kopečková, P., and Kopeček, J. (1999) High-molecular weight HPMA copolymer-adriamycin conjugates. J. Control. Release, 60, 321-332.
32. Shiah, J.-G., Dvořák, M., Kopečková, P., Sun, Y., Peterson, C.M., and Kopeček, J. (2001) Biodistribution and antitumor efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur.J. Cancer, 37, 131-139.
33. McCormick, L.A., Seymour, L.C.W., Duncan, R., and Kopeček, J. (1986) Interaction of a cationic N-(2-hydroxypropyl)methacrylamide copolymer with rat visceral yolk sac cultured in vitro and rat liver in vivo. J. Bioact. Compat. Polym., 1, 901-905.
34. Mukherjee, S., Ghosh, R.N., and Maxfield, F.R. (1997) Endocytosis. Physiol. Rev., 77, 759-803.
35. Mayor, S., and Pagano, R.E. (2007) Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol., 8, 603-612.
36. Gong, Q., Huntsman, C., and Ma, D. (2008) Clathrin-independent internalization and recycling. J. Cell Mol. Med., 12, 126-144.
37. Praefcke, G.J., and McMahon, H.T. (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat. Rev. Mol. Cell Biol., 5, 133-147.
38. Jones, A.T. (2007) Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell Mol. Med., 11, 670-684.
39. Kerr, M.C., and Teasdale, R.D. (2009) Defining macropinocytosis. Traffic, 10, 364-371.
40. Duncan, R., Rejmanová, P., Kopeček, J., and Lloyd, J.B. (1981) Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system. Biochim. Biophys. Acta, 678, 143-150.
41. Duncan, R., Cable, H.C., Rejmanová, P., Kopeček, J., and Lloyd, J.B. (1984) Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers. Biochim. Biophys. Acta, 799, 1-8.
42. Liu, J., Kopečková, P., Bühler, P., Wolf, P., Pan, H., Bauer, H., Elsässer-Beile, U., and Kopeček, J. (2009) Biorecognition and subcellular trafficking of HPMA copolymer-anti-PMSA antibody conjugates by prostate cancer cells. Mol. Pharm., 6, 959-970.
43. Callahan, J., Kopečková, P., and Kopeček, J. (2009) The intracellular trafficking and subcellular distribution of a large array of HPMA copolymer conjugates. Biomacromolecules, 10, 1704-1714.
44. Tijerina, M., Kopečková, P., and Kopeček, J. (2003) Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells. Pharm. Res., 20, 728-737.
45. Tijerina, M., Kopečková, P., and Kopeček, J. (2003) Mechanism of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates. Photochem. Photobiol., 77, 645-652.
46. Panté, N., and Kann, M. (2002) Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol. Biol. Cell, 13, 425-434.
47. Paine, P.L., Moore, L.C., and Horowitz, S.B. (1975) Nuclear envelope permeability. Nature, 254, 109-114.
48. Feldherr, C.M., and Akin, D. (1997) The location of the transport gate in the nuclear pore complex. J. Cell Sci., 110, 3065-3070.
49. Frey, S., Richter, R.P., and Görlich, D. (2006) FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties. Science, 314, 815-817.
50. Bohdanecký, M., Bažilová, H., and Kopeček, J. (1974) Poly[N-(2- hydroxypropyl)methacrylamide]. II. Hydrodynamic properties of dilute solutions. Eur. Polym.J., 10, 405-410.
51. Koňák, Č., Kopečková, P., and Kopeček, J. (1992) Photoregulated association of N-(2-hydroxypropyl)methacrylamide copolymers with azobenzene containing side-chains. Macromolecules, 25, 5451-5456.
52. Kopeček, J., Kopečková, P., and Koňák, Č. (1997) Biorecognizable polymers: design, structure, and bioactivity. J. Macromol. Sci. Pure Appl. Chem., A34, 2103-2117.
53. Shiah, J.G., Koňák, Č., Spikes, J.D., and Kopeček, J. (1997) Solution and photoproperties of N-(2-hydroxypropyl)methacrylamide copolymer-meso-chlorin e6 conjugates. J. Phys. Chem., B101, 6803-6809.
54. Shiah, J.G., Koňák, Č., Spikes, J.D., and Kopeček, J. (1998) Influence of pH on aggregation and photoproperties of N-(2-hydroxypropyl)methacrylamide copolymer-meso-chlorin e6 conjugates. Drug Deliv., 5, 119-126.
55. Ulbrich, K., Koňák, Č., Tuzar, Z., and Kopeček, J. (1987) Solution properties of drug carriers based on poly[N-(2-hydroxypropyl)methacrylamide] containing biodegradable bonds. Makromol. Chem., 188, 1261-1272.
56. Noda, T., and Morishima, Y. (1999) Hydrophobic association of random copolymers of sodium 2-(acrylamido)-2- methylpropanesulfonate and dodecyl methacrylate in water as studied by fluorescence and dynamic light scattering. Macromolecules, 32, 4631-4640.
57. Nagayama, T., Hashidzume, A., and Morishima, Y. (2002) Characterization of self-association in water of polycations hydrophobically modified with hydrocarbon and siloxane chains. Langmuir, 18, 6775-6782.
58. Sparr, E., Ash, W.L., Nazarov, P.V., Rijkers, D.T., Hemminga, M.A., Tieleman, D.P., and Killian, J.A. (2005) Self-association of transmembrane alpha-helices in model membranes: importance of helix orientation and role of hydrophobic mismatch. J. Biol. Chem., 280, 39324-39331.
59. Itaka, K., Harada, A., Nakamura, K., Kawaguchi, H., and Kataoka, K. (2002) Evaluation of fluorescence resonance energy transfer of the stability of nonviral gene delivery vectors under physiological conditions. Biomacromolecules, 3, 841-845.
60. Itaka, K., Harada, A., Yamasaki, Y., Nakamura, K., Kawaguchi, H., and Kataoka, K. (2004) In situ single cell observation of fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethyleneimine. J. Gene Med., 6, 76-84.
61. Ding, H., Prodinger, W.M., and Kopeček, J. (2006) Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates. Biomacromolecules, 7, 3037-3046.
62. Pan, H., Kopečková, P., Wang, D., Yang, J., Miller, S., and Kopeček, J. (2006) Water-soluble HPMA copolymer-prostaglandin E1 conjugates containing a cathepsin K sensitive spacer. J. Drug Target., 14, 425-435.
63. Lee, B.S., Fujita, M., Khazenzon, N.M., Wawrowsky, K.A., Wachsmann-Hogiu, S., Farkas, D.L., Black, K.L., Ljubimova, J.Y., and Holler, E. (2006) Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-l -malic acid) for drug delivery. Bioconjug. Chem., 17, 317-326.
64. Ding, H., Kopečková, P., and Kopeček, J. (2007) Self-association properties of HPMA copolymers containing an amphipathic heptapeptide. J. Drug Target., 15, 465-474.
65. Ulbrich, K., and Šubr, V. (2010) Structural and chemical aspects of HPMA copolymers as drug carriers. Adv. Drug Deliv. Rev., 62, 150-166.
66. Fox, M.E., Szóka, F.C., and Fréchet, J.M. (2009) Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc. Chem. Res., 42, 1141-1151.
67. '- butylurea. J. Polym. Sci. Polym. Symp., 66, 41-52.
68. Chytrý, V., Vrána, A., and Kopeček, J. (1978) Synthesis and activity of a polymer which contains insulin covalently bound on a copolymer of N-(2-hydroxypropyl)methacrylamide and N-methacryloylglycylglycine 4-nitrophenyl ester. Makromol. Chem., 179, 329-336.
69. Solovskij, M.V., Ulbrich, K., and Kopeček, J. (1983) Synthesis of N-(2-hydroxypropyl)methacrylamide copolymers with antimicrobial activity. Biomaterials, 4, 44-48.
70. Shen, W.-C., and Ryser, H.J.-P. (1981) Cis-aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem. Biophys. Res. Commun., 102, 1048-1054.
71. Chytil, P., Etrych, T., Koňák, Č., Šírová, M., Mrkvan, T., Říhová, B., and Ulbrich, K. (2006) Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification. J. Control. Release, 115, 26-36.
72. Kopeček, J., Rejmanová, P., and Chytrý, V. (1981) Polymers containing enzymatically degradable bonds 1. Chymotrypsin catalyzed hydrolysis of p-nitroanilides of phenylalanine and tyrosine attached to side-chains of copolymers of N-(2-hydroxypropyl)methacrylamide. Makromol. Chem., 182, 799-809.
73. Ulbrich, K., Strohalm, J., and Kopeček, J. (1981) Polymers containing enzymatically degradable bonds. 3. Poly[N-(2-hydroxypropyl)methacrylamide] chains connected by oligopeptide sequences cleavable by trypsin. Makromol. Chem., 182, 1917-1928.
74. Ulbrich, K., Zacharieva, E.I., Obereigner, B., and Kopeček, J. (1980) Polymers containing enzymatically degradable bonds. 5. Hydrophilic polymers degradable by papain. Biomaterials, 1, 199-204.
75. Kopeček, J. (1984) Controlled degradability of polymers - a key to drug delivery systems. Biomaterials, 5, 19-25.
76. Kopeček, J., Cífková, I., Rejmanová, P., Strohalm, J., Obereigner, B., and Ulbrich, K. (1981) Polymers containing enzymatically degradable bonds. 4. Preliminary experiments in vivo. Makromol. Chem., 182, 2941-2949.
77. Duncan, R., Cable, H.C., Lloyd, J.B., Rejmanová, P., and Kopeček, J. (1983) Polymers containing enzymatically degradable bonds. 7. Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] copolymers to promote efficient degradation by lysosomal enzymes. Makromol. Chem., 184, 1997-2008.
78. Šubr, V., Kopeček, J., Pohl, J., Baudyš, M., and Kostka, V. (1988) Cleavage of oligopeptide side-chains in N-(2-hydroxypropyl)methacrylamide copolymers by mixtures of lysosomal enzymes. J. Control. Release, 8, 133-140.
79. Rejmanová, P., Pohl, J., Baudyš, M., Kostka, V., and Kopeček, J. (1983) Polymers containing enzymatically degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B. Makromol. Chem., 184, 2009-2020.
80. Toki, B.E., Cerveny, C.G., Wahl, A.F., and Senter, P.D. (2002) Protease-mediated fragmentation of p-amidobenzyl ethers: a new strategy for the activation of anticancer prodrugs. J. Org. Chem., 67, 1866-1872.
81. Gao, S.-Q., Lu, Z.-R., Petri, B., Kopečková, P., and Kopeček, J. (2006) Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer. J. Control. Release, 110, 323-331.
82. Gao, S.-Q., Sun, Y., Kopečková, P., Peterson, C.M., and Kopeček, J. (2009) Antitumor efficacy of colon-specific HPMA copolymer-9-aminocamptothecin conjugates in mice bearing human colon carcinoma xenografts. Macromol. Biosci., 9, 1135-1142.
83. ' conjugates targeted to the B-cell antigen. Bioconjug. Chem., 20, 129-137.
84. Tang, A., Kopečková, P., and Kopeček, J. (2003) Binding and cytotoxicity of HPMA copolymers to lymphocytes mediated by receptor-binding epitopes. Pharm. Res., 20, 360-367.
85. Omelyanenko, V., Kopečková, P., Gentry, C., Shiah, J.-G., and Kopeček, J. (1996) HPMA copolymer-anticancer drug-OVTL16 antibody conjugates. 1. Influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J. Drug Target., 3, 357-373.
86. Cuchelkar, V., Kopečková, P., and Kopeček, J. (2008) Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting. Mol. Pharm., 5, 696-709.
87. Nori, A., and Kopeček, J. (2005) Intracellular targeting of polymer-bound drugs for cancer chemotherapy. Adv. Drug Deliv. Rev., 57, 609-636.
88. Muratovska, A., Lightowlers, R.N., Taylor, R.W., Turnbull, D.M., Smith, R.A., Wilce, J.A., Martin, S.W., and Murphy, M.P. (2001) Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res., 29, 1852-1863.
89. Callahan, J., and Kopeček, J. (2006) Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization. Biomacromolecules, 7, 2347-2356.
90. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R.M. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
91. Williams, S.P., and Sigler, P.B. (1998) Atomic structure of progesterone complexed with its receptor. Nature, 393, 392-396.
92. Rebuffat, A., Bernasconi, A., Ceppi, M., Wehrli, H., Brenz Verca, S., Ibrahim, M., Frey, B.M., Frey, F.J., and Rusconi, S. (2001) Selective enhancement of gene transfer by steroid-mediated gene delivery. Nat. Biotechnol., 19, 1155-1161.
93. Cuchelkar, V. (2008) Strategies for enhancing the photodynamic effect of N-(2-hydroxypropyl)methacrylamide copolymer bound mesochlorin e6 PhD Dissertation, Department of Bioengineering, University of Utah.
94. Yang, J., Luo, K., Pan, H., Kopečková, P., and Kopeček, J. (2011) Synthesis of biodegradable multiblock copolymers by click coupling of RAFT-generated heterotelechelic polyHPMA conjugates. Reactive Funct. Polym., 71, 294-302.
95. Luo, K., Yang, J., Kopečková, P., and Kopeček, J. (2011) Biodegradable multiblock N-(2-hydroxypropyl)methacrylamide copolymers via reversible addition-fragmentation chain transfer polymerization and click chemistry. Macromolecules, 44, 2481-2488.
96. Pan, H., Yang, J., Kopečková, P., and Kopeček, J. (2011) Backbone degradable multiblock N-(2-hydroxypropyl)methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction. Biomacromolecules, 12, 247-252.
97. Quémener, D., Davis, T.P., Barner-Kowollik, C., and Stenzel, M.H. (2006) RAFT and click chemistry: a versatile approach to well-defined block copolymers. Chem. Commun., 5051-5053.
98. Golas, P.L., Tsarevsky, N.V., Sumerlin, B.S., Walker, L.M., and Matyjaszewski, K. (2007) Multisegmented block copolymers by ''click'' coupling of polymers prepared by ATRP. Aust.J. Chem., 60, 400-404.
99. Kopeček, J., and Yang, J. (2009) Peptide-directed self-assembly of hydrogels. Acta Biomater., 5, 805-816.
100. Yang, J., Xu, C., Wang, C., and Kopeček, J. (2006) Refolding hydrogels self-assembled from N-(2-hydroxypropyl)methacrylamide graft copolymers by antiparallel coiled-coil formation. Biomacromolecules, 7, 1187-1195.
101. Yang, J., Wu, K., Koňák, Č., and Kopeček, J. (2008) Dynamic light scattering study of the self-assembly of HPMA hybrid graft copolymers. Biomacromolecules, 9, 510-517.
102. Wu, K., Liu, J., Johnson, R.N., Yang, J., and Kopeček, J. (2010) Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface. Angew. Chem. Int. Ed., 49, 1451-1455.
103. Deans, J.P., Li, H., and Polyak, M.J. (2002) CD20-mediated apoptosis: signaling through lipid rafts. Immunology, 107, 176-182.
104. Golay, J.T., Clark, E.A., and Beverley, P.C. (1985) The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle. J. Immunol., 135, 3795-3801.
105. Anderson, K.C., Bates, M.P., Slaugenhoupt, B.L., Pinkus, G.S., Schlossman, S.F., and Nadler, L.M. (1984) Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood, 63, 1424-1433.
106. Press, O.W., Appelbaum, F., Ledbetter, J.A., Martin, P.J., Zarling, J., Kidd, P., and Thomas, E.D. (1987) Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood, 69, 584-591.
107. Kopeček, J. (2010) Biomaterials and drug delivery: past, present, and future. Mol. Pharm., 7, 922-925.